Clinical studies have reported that early introduction of peanuts to the diet for infants proved to be safe and it caused reductions in development of peanut allergy in 81%. The Studies concerned with infants who were in a group of high risk of developing allergy. The research was supported by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health, and were conducted by the Immune Tolerance Network (ITN). The results of the research appeared on the pages of the New England Journal of Medicine and were presented at the annual meeting of the American Academy of Allergy, Asthma and Immunology.
Sublingual immunotherapy (SLIT) due to its convenient administration and clinical efficiency has become popular treatment option for allergic diseases in Europe. Recently, the group of Indian scientists (Balaji R et al.) evaluated safety, tolerability and clinical efficacy of ultra-rush sublingual immunotherapy among patients suffering from allergic rhinitis (AR). The results of the study, which were published in “Allergologia et immunopatologia”, confirmed the thesis that this novel therapy might reduce symptoms of AR without risk of severe adverse effects. Ultra-rush sublingual immunotherapy with short period of treatment can have better compliance. Read full text »
Exposure to mold during infancy increases the risk of asthma. Tendency to development of asthma is three times higher among children living in mold contaminated areas. More on this topic can be found in the August issue of Annals of Allergy, Asthma & Immunology, scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI). Read full text »
Gastric bacterium Helicobacter pylori causes ulcer disease. New results published in the Journal of Clinical Investigation revealed that infection protects against allergy-induced asthma. Read full text »